TransEnterix, Inc.

TransEnterix, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on May 25, 2018 and the most recent on May 25, 2018 (TransEnterix Senhance Surgical System). Its most common review panel is Gastroenterology-Urology (1 device).